Eurofins Newsletters

Pharma Services

The Eurofins Group publishes a Pharma Services newsletter, presenting new services and analytical techniques, research projects, major events and other related topics. The newsletter is published 3 times per year.

Biopharma Newsletter 34 - February 2023

ARTICLES:

• TruGraf Liver, the first and only gene expression diagnostic that helps optimise immunosuppression treatment for liver transplant patients
• TEM is the ideal complement to in-vitro assays and molecular techniques in determining the microbiological safety of biological products
• Ensuring consumer safety and regulatory compliance for OTC drugs, cosmetic products, and dietary supplements
• Eurofins Discovery helps researchers understand human toxicities related to PFAS
• Celebrating 35 years of Testing for Life – 35 YEARS OF EUROFINS
• Eurofins BioPharma Product Testing offers comprehensive testing services to qualify filters for sterile drug manufacturing

Download the PDF version of pharma newsletter N°34